Article info
PDFClinical/translational cancer immunotherapy
Original research
Activation of MAT2A-RIP1 signaling axis reprograms monocytes in gastric cancer
- Correspondence to Dr Mingzhe Ma, Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; mmz666{at}163.com; Professor YiRen Hu, Department of General Surgery, Wenzhou No.3 Clinical Institute of Wenzhou Medical University, Wenzhou People's Hospital, Wenzhou, China; yirenhu{at}hotmail.com; Dr Kun Lv, Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution, Wuhu, China; lvkun315{at}126.com; Dr Xi Yang, Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China; woshi358539575{at}gmail.com
Citation
Activation of MAT2A-RIP1 signaling axis reprograms monocytes in gastric cancer
Publication history
- Accepted January 7, 2021
- First published February 16, 2021.
Online issue publication
January 26, 2023
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.